Technology developed by WEI investigator Joshua Coon for GLBRC research is now helping speed up testing of antibody-based medicines through UW–Madison startup CeleramAb.
Read more: energy.wisc.edu/news/invented-…
Read more: energy.wisc.edu/news/invented-…